Ironwood (IRWD) Q2 Earnings Miss, Keeps 2022 Sales Guidance

This article was originally published on Nasdaq

Ironwood Pharmaceuticals, Inc. IRWD reported second-quarter 2022 adjusted earnings of 21 cents per share, missing the Zacks Consensus Estimate of 31 cents. The company had reported adjusted earnings of 34 cents per share in the year-ago quarter.

Responses